SOURCE: Accredited Business Consolidators Corp.
DOYLESTOWN, PA--(Marketwire - Nov 30, 2012) - AccreditedRX.com formulated a solution to expensive consumer drug prescriptions. Now consumers may purchase prescription drugs from most chain drugstores at negotiated bulk prices as if they were members of a plan. By visiting AccreditedRX.com, consumers print out a coupon usable at most major pharmacies to obtain their prescriptions at discounted prices. There is no cost to the consumer.
The free prescription discount coupon can be used over and over again and does not expire. Discounts on prescription drugs will range from 10% to 85% of the retail price. Consumers with insurance can ask the pharmacist to determine if their copay is higher than the cost of the prescription with our discount card.
For consumers without the ability to log on our website, they can obtain the discounts by providing the pharmacist with the AccreditedRX.com codes and asking the pharmacy to enter the discount. The consumer should advise the pharmacist of the discount codes as follows:
Member ID: The consumer's phone number
These contract codes are accepted at most pharmacies including the major chains such as Walgreens, Walmart, Discount Drug Mart, Target Pharmacy, K-Mart, Fred Meyer Pharmacy, Sav-More Drugs, Rite-Aid and most others. The discounts also apply to prescriptions for pet medicine as well.
Over the next two weeks, AccreditedRx.com will begin an affiliate program where sales persons, website owners, and professionals can distribute discount prescription cards to their customers and receive an incentive payment.
AccreditedRX.com is a venture between R.S.S. Marketing and Accredited Business Consolidators Corp. (OTCQB: ACDU). There is no cost to the consumer, fees are paid by the drug manufacturers. AccreditedRX.com allows consumers to purchase prescription drugs from most pharmacies at negotiated discount prices. ACDU, a partner in the venture, trades on the OTCQB over the counter stock market. ACDU's authorized common shares are 450,000,000. 436,399,566 shares are outstanding of which 70,546,600 are restricted.
This is not an offer to sell securities. Statements made are forward-looking subject to risks and uncertainties. Statements included are made as of the date hereof, and the company undertakes no obligation to update such statements to reflect subsequent events or circumstances. Actual results could differ materially from anticipated results.